Tomoko Tsuchiya
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
The small ubiquitin-like modifier SUMO-3 acts as a neutrophil chemoattractant via the chemokine receptors CXCR1 and CXCR2.
Journal: Journal of innate immunity
Published: January 08, 2026
CXCL17 binds efficaciously to glycosaminoglycans with the potential to modulate chemokine signaling.
CXCL17 binds efficaciously to glycosaminoglycans with the potential to modulate chemokine signaling.
Journal: Frontiers in immunology
Published: July 07, 2023
Extracting information content on radiation risks from the receiver perspective: Examining Fukushima residents 10 years after the Fukushima nuclear reactor accident.
Journal: Risk analysis : an official publication of the Society for Risk Analysis
Published: June 26, 2023
Development of the clinical competency assessment scale in child and adolescent mental health nursing.
Journal: Journal of psychiatric and mental health nursing
Published: March 30, 2023
A possible way to prevent the progression of bone lesions in multiple myeloma via Src-homology-region-2-domain-containing-phosphatase-1 activation.
Journal: Journal of cellular biochemistry
Published: January 13, 2021
Anti-Metastatic Benefits Produced by Hyperthermia and a CCL3 Derivative.
Journal: Cancers
Published: October 25, 2019
A Requirement for Neutrophil Glycosaminoglycans in Chemokine:Receptor Interactions Is Revealed by the Streptococcal Protease SpyCEP.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: January 04, 2019
Evidence for the Existence of a CXCL17 Receptor Distinct from GPR35.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: June 16, 2017
CXCL4/Platelet Factor 4 is an agonist of CCR1 and drives human monocyte migration.
Journal: Scientific reports
Published: March 10, 2016
Alarmins released during local antitumor treatments play an essential role in enhancing tumor growth inhibition at treated and non-treated sites via a derivative of CCL3.
Journal: Oncoimmunology
Published: August 20, 2014
A novel liposome surface modification agent that prolongs blood circulation and retains surface ligand reactivity.
Journal: Journal of biomaterials science. Polymer edition
Published: November 08, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026